Ftse Mib
33.766,29
-0,06%
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
NASDAQ
19.572,60
1,03%
Bitcoin
97.119,39
-0,65%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Aadi Bioscience Inc (AADI) Aadi Bioscience Inc (AADI) Notizie

Aadi Bioscience Inc

AADI
3,03
0,71 (30,60%)
21 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
20/12/202412:08EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
20/12/202412:05EDGAR2Form 8-K - Current report
20/12/202400:30PRNUSAadi Bioscience Transforms with In-Licensing of Novel ADC..
06/11/202422:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202414:05EDGAR2Form 8-K - Current report
06/11/202414:00PRNUSAadi Bioscience Announces Financial Results for the Third..
30/10/202421:05PRNUSAadi Bioscience to Report Third Quarter 2024 Results and..
04/10/202401:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202401:01EDGAR2Form 144 - Report of proposed sale of securities
01/10/202423:35EDGAR2Form SC 13D/A - General Statement of Acquisition of..
30/9/202412:06EDGAR2Form 8-K - Current report
19/9/202422:13EDGAR2Form 8-K - Current report
05/9/202423:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/9/202423:51EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
03/9/202416:40EDGAR2Form 144 - Report of proposed sale of securities
22/8/202422:15EDGAR2Form 8-K - Current report
21/8/202403:21EDGAR2Form 8-K - Current report
20/8/202423:00PRNUSAadi Bioscience Provides PRECISION1 Trial and Corporate..
07/8/202422:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202414:02EDGAR2Form 8-K - Current report
07/8/202414:00PRNUSAadi Bioscience Announces Financial Results for the Second..
06/8/202400:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/7/202422:05PRNUSAadi Bioscience to Report Second Quarter 2024 Results and..
14/6/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202422:18EDGAR2Form 8-K - Current report
05/6/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202418:26EDGAR2Form 144 - Report of proposed sale of securities
29/5/202422:05PRNUSAadi Bioscience to Participate in the Jefferies Healthcare..
23/5/202423:30PRNUSAadi Bioscience Presents New Nonclinical Data Demonstrating..
08/5/202422:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202414:07EDGAR2Form 8-K - Current report
08/5/202414:00PRNUSAadi Bioscience Announces Financial Results for the First..
01/5/202414:01PRNUSAadi Bioscience to Report First Quarter 2024 Results and..
09/4/202414:00PRNUSAadi Bioscience to Present New Non-clinical Data..
17/3/202413:00PRNUSAadi Bioscience Presents New Subgroup Analysis of Patients..
13/3/202413:00PRNUSAadi Bioscience Announces Financial Results for the Fourth..
06/3/202414:00PRNUSAadi Bioscience to Report Fourth Quarter and Full-Year 2023..
05/3/202422:30PRNUSAadi Bioscience to Present Multiple Posters at the American..
05/3/202401:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202401:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202401:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202422:08PRNUSAadi Bioscience Announces Publication of Long-Term Efficacy..
01/3/202419:07EDGAR2Form 144 - Report of proposed sale of securities
26/2/202422:05PRNUSAadi Bioscience to Present at the TD Cowen 44th Annual..
12/2/202423:21EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/2/202423:16EDGAR2Form S-3 - Registration statement under Securities Act of..
Apertura: 2,52 Min: 2,07 Max: 3,60
Chiusura: 2,32

La tua Cronologia

NASDAQ
AADI
Aadi Bioscience
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network